Transmissible Venereal Tumor in Dogs: Symptoms, Treatment & Prognosis

Understanding Transmissible Venereal Tumors in Dogs

Transmissible venereal tumors (TVT), also known as canine transmissible venereal tumors or sticker tumors, are a unique type of cancer that spreads directly from dog to dog through sexual contact or other direct contact with infected tissues. Unlike most cancers, TVT is not inherited or caused by environmental factors but rather transmitted between individual animals. This specialized tumor has fascinated veterinary oncologists for decades because it represents one of the few naturally occurring transmissible cancers in the animal kingdom.

TVT is primarily found in the genital regions of dogs but can occasionally appear on the nose, mouth, eyes, or skin if a dog has contact with an infected area through sniffing or licking. Understanding this condition is essential for dog owners, particularly those with unspayed or unneutered dogs that have access to other animals. The good news is that modern veterinary medicine has developed highly effective treatment protocols that result in excellent outcomes for most affected dogs.

What Causes Transmissible Venereal Tumors?

Unlike most cancers that develop from genetic mutations or environmental exposure, TVT is caused by direct transmission of cancer cells from one dog to another. The tumor is spread through contact with infected tissue, most commonly during mating or other close physical contact between dogs. The cancer cells themselves are what transmit the disease, making it unique among canine malignancies.

TVT can affect dogs of any age, breed, or sex, though it is more commonly seen in populations with higher rates of stray animals and uncontrolled breeding. Dogs that spend time in shelters, roam freely unsupervised, or are used for breeding purposes face increased risk of exposure. The disease is not species-specific to dogs alone; similar transmissible tumors have been documented in other animal species, further emphasizing the unusual nature of this condition.

Recognizing the Signs and Symptoms

Early detection of TVT is crucial for successful treatment. Dog owners should be alert to several warning signs that may indicate the presence of a transmissible venereal tumor.

Genital Symptoms

In male dogs, TVT typically affects the penis and prepuce (sheath), while in female dogs, it affects the vulva. Owners may notice a painful mass protruding from the genital area that has a characteristic cauliflower-like appearance. Common genital symptoms include:

• Bleeding, oozing, or unusual discharge from the genital area
• Painful masses that may be tender to the touch
• Urinary retention caused by blockage of the urethra if the tumor becomes large enough
• Excessive licking or attention to the genital region
• Difficulty urinating or straining during urination

Extragenital Symptoms

While less common, TVT can develop outside the genital region, particularly affecting the nasal passages and oral cavity. These presentations occur when a dog has direct contact with infected tissue through sniffing or licking. Extragenital symptoms include:

• Nasal discharge or nosebleeds
• Facial swelling or visible masses in the nose or mouth
• Enlargement of submandibular lymph nodes
• Nasal fistulae (abnormal openings) in severe cases

General Warning Signs

Beyond localized symptoms, affected dogs may exhibit general signs of illness including lethargy, decreased appetite, or behavioral changes. Any dog displaying these symptoms should be evaluated by a veterinarian promptly, though most cases warrant a standard veterinary appointment rather than emergency care unless the dog is experiencing severe pain or inability to urinate.

Transmission and Prevention

Understanding how TVT spreads is essential for preventing transmission between dogs. The tumor is transmitted through direct contact with infected tissue, most commonly during sexual contact between intact (unspayed or unneutered) dogs. However, transmission can also occur through other forms of direct contact with the tumor surface.

Risk Factors for Transmission

Several factors increase the likelihood of TVT transmission:

• Contact with stray or unowned dogs
• Housing in shelters or rescue facilities with multiple dogs
• Uncontrolled breeding practices
• Geographic location in areas with large stray dog populations
• Intact reproductive status (not spayed or neutered)

Prevention Strategies

The most effective prevention strategies involve limiting exposure and managing reproductive status. Spaying and neutering significantly decrease the risk of developing or spreading TVT between dogs. Additionally, preventing contact between pets and stray dogs substantially reduces transmission risk. Dogs diagnosed with TVT should not have contact with other dogs until a veterinarian confirms that the disease has been completely cured.

Diagnosis of Transmissible Venereal Tumors

Veterinary diagnosis of TVT typically involves a combination of physical examination and diagnostic testing. During the physical exam, a veterinarian will evaluate the tumor’s location, size, appearance, and any associated symptoms. The characteristic cauliflower-like appearance of genital TVT often provides strong diagnostic clues.

Definitive diagnosis is usually confirmed through cytology (examination of cells) or histopathology (examination of tissue samples). A veterinarian may perform a fine needle aspiration or biopsy to collect cells for microscopic examination. These diagnostic procedures help confirm TVT and rule out other potential conditions that may present similarly.

Treatment Options for TVT

Fortunately, transmissible venereal tumors are highly treatable, with excellent prognosis for complete recovery in most cases. Multiple effective treatment modalities are available, and a veterinarian will recommend the most appropriate approach based on individual patient factors.

Chemotherapy: The Gold Standard Treatment

Chemotherapy is currently the treatment of choice for TVT and is the most effective option available. The most commonly used chemotherapy drug is vincristine sulfate, which is administered intravenously on a weekly basis.

Vincristine Treatment Protocol:

• Typical dosing: 0.025 mg/kg IV, once per week
• Treatment duration: Usually fewer than 10 visits are needed
• Response rate: 93.1% complete response rate with 4-6 sessions, increasing to 98.9% with 8 sessions
• Administration: Weekly intravenous injections on an outpatient basis
• Complete remission typically achieved in 5-7 doses

The treatment course usually consists of ongoing injections until complete resolution of the gross tumor mass is achieved. Most dogs respond extremely well to vincristine, with the majority experiencing complete tumor regression. For single tumors, injecting the chemotherapy medication directly into the tumor for one to four treatments, combined with interleukin-2 (a compound that enhances immune system function), is typically very effective, with one treatment cycle often being sufficient.

Dogs receiving chemotherapy require monitoring to ensure they are tolerating treatment appropriately, as chemotherapy can affect the immune system by temporarily decreasing white blood cell counts. Some dogs may experience side effects including fever, nausea, vomiting, decreased appetite, or general malaise during treatment. These side effects are usually manageable and temporary.

Alternative Chemotherapy Agents

While vincristine is the first-line chemotherapy choice, alternative agents are available for dogs that do not respond adequately to vincristine or that develop resistance. These alternatives include:

• Doxorubicin: An effective alternative for vincristine-resistant cases, typically administered every three weeks for 5-6 doses
• Lomustine: Available as a second-line treatment option
• Vinblastine: Another effective chemotherapy agent used in TVT treatment

Radiation Therapy

Radiation therapy is an excellent alternative treatment option, particularly for dogs that cannot receive chemotherapy or do not respond adequately to chemotherapy agents. Two primary types of radiation therapy are available:

Conventionally Fractionated Radiation Therapy (CFRT): This approach uses lower radiation doses but requires a higher number of treatments, typically 16 to 18 sessions. While effective, this extended treatment schedule requires multiple anesthesia episodes, which can be challenging for some patients.

Stereotactic Radiation (SRS/SRT): This more innovative option targets the tumor with high doses of radiation designed to kill cancer cells while minimizing damage to surrounding healthy tissue. Stereotactic radiation typically consists of just one to three treatments, making it particularly beneficial since dogs must be anesthetized for radiation therapy. This approach significantly reduces the number of anesthesia episodes required and can provide curative results.

Radiation can be curative for TVT and is restricted to specialized veterinary facilities. In some cases, a single radiation session can effectively treat the tumor.

Surgical Intervention

Complete surgical excision can be an effective treatment option for accessible small tumors that have not spread to other locations. However, surgery alone often leads to recurrence due to the anatomical location of many of these tumors. Surgery may be difficult or impossible depending on tumor location, and adjunctive radiation or chemotherapy is often necessary to prevent recurrence if surgery is attempted.

Treatment Response and Prognosis

The prognosis for dogs diagnosed with TVT is excellent, particularly when treatment is initiated promptly. Modern treatment protocols result in complete remission in nearly all cases of transmissible venereal tumors.

Factors Affecting Treatment Response

Several factors influence how quickly and effectively a dog responds to treatment:

• Tumor size: Smaller tumors typically respond more quickly to treatment than larger tumors
• Patient age: Younger dogs generally show better treatment response than older dogs
• Environmental conditions: Hot and humid seasons are typically associated with poorer treatment response
• Metastatic spread: Tumors that have spread to distant organs have a poorer prognosis, particularly if CNS or ocular involvement is present

Spontaneous Regression

In rare cases, spontaneous regression (natural decrease in tumor size) may occur without treatment. If spontaneous regression is going to happen, it typically begins within three months of transmission. However, if a dog has had the tumor for nine months without evidence of regression, spontaneous remission is unlikely to occur. Most TVTs require veterinary intervention, making prompt treatment crucial.

Recovery and Management

With recommended treatment, the prognosis for TVT is good in otherwise healthy dogs, regardless of tumor location or whether metastasis has occurred. Recovery typically involves:

• Regular veterinary monitoring during and after treatment
• Potential use of anti-inflammatory medications like carprofen to decrease pain and inflammation
• Restriction of contact with other dogs until the disease has been completely cured
• Management of any treatment side effects

Important Considerations for Dog Owners

Several important facts should guide owner decisions regarding TVT management and prevention:

• Non-transmissible to humans: TVT does not spread to humans, though owners should wear gloves when touching the tumor
• Recurrence risk: Dogs can develop TVT again after the initial tumor has been cured, making prevention measures ongoing priorities
• Disease progression without treatment: Without surgery or medical intervention, most dogs will continue to have the tumor, which may become resistant to treatment and could spread to other dogs
• Pain management: These tumors are uncomfortable for affected dogs, as masses often develop sores and bleed, and pets may want to lick them

Frequently Asked Questions About Transmissible Venereal Tumors

Q: Can TVT in dogs be cured?

A: Yes, TVT can be cured. Surgery is an option for accessible small tumors that have not spread. Other TVTs are often cured with just one chemotherapy or radiation treatment, though multiple treatment sessions may be necessary in some cases.

Q: Can dogs spread TVT to humans?

A: No, TVT does not spread to humans. However, you should wear gloves if you touch the tumor to maintain good hygiene practices.

Q: How long does TVT treatment typically take?

A: Chemotherapy treatment typically involves weekly injections for usually fewer than 10 visits. Most dogs achieve complete remission within 5-7 doses of vincristine. Radiation therapy may require as few as one to three treatments with stereotactic radiation, or 16-18 treatments with conventional fractionated radiation.

Q: What are the side effects of chemotherapy for TVT?

A: Common side effects include fever, nausea, vomiting, decreased appetite, and temporary reduction in white blood cell counts. Your veterinarian will monitor your dog throughout treatment and manage any side effects that occur.

Q: Can my dog get TVT again after treatment?

A: Yes, dogs can develop TVT again after the initial tumor has been cured. Prevention includes spaying or neutering your dog and preventing contact with stray dogs or other dogs that may carry the disease.

Q: Is emergency care necessary if my dog has TVT?

A: Most TVT cases warrant a standard veterinary appointment rather than emergency care. However, if your dog is in severe pain or unable to urinate due to tumor obstruction, immediate veterinary attention is necessary.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete